Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs
- PMID: 15016490
- DOI: 10.1016/S0140-6736(04)15695-X
Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs
Abstract
Mesenchymal stromal cells (MSCs) have the potential to treat many myocardial diseases. We investigated whether these multipotent stem cells derived from bone marrow could be administered safely into the coronary circulation of healthy dogs. We injected about 0.5 million cells per kg bodyweight of early passage autologous MSCs into the left circumflex coronary artery of anaesthetised dogs. During administration, we noted ST segment elevation and T wave changes characteristic of acute myocardial ischaemia. 7 days later, macroscopic and microscopic evidence of myocardial infarction was noted. Histological sections of myocardium showed several scattered regions of dense fibroplasia accompanied by macrophage infiltrates only in areas where the MSCs were observed. We also noted raised plasma concentrations of cardiac troponin I and collagen fibril deposition in the lesions. These findings show acute myocardial ischaemia and subacute myocardial microinfarction after intracoronary arterial injection of MSCs into dogs.
Comment in
-
Risk to the coronary arteries of intracoronary stem cell infusion and G-CSF cytokine therapy.Lancet. 2004 Mar 6;363(9411):746-7. doi: 10.1016/S0140-6736(04)15713-9. Lancet. 2004. PMID: 15016481 No abstract available.
-
Stem-cell therapy for myocardial diseases.Lancet. 2004 May 22;363(9422):1735-6. doi: 10.1016/S0140-6736(04)16270-3. Lancet. 2004. PMID: 15158647 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
